Topiramate — an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder — does not appear to increase the risk of autism spectrum disorder (ASD) among children exposed to it prenatally, according to a new study led by Harvard T.H. Chan School of Public Health.

From Krista F. Huybrechts and colleagues, first author Sonia Hernández-Díaz. Read more in the Harvard Gazette.